Mesoblast Limited a annoncé que son essai clinique pivot de phase 3, évaluant le rexlemestrocel-L pour le traitement de la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results